
Sanofi is steadily recovering from missing out on Actelion to J&J by making another deal, this time with Ablynx biotech …
Ablynx has secured €1 million from Novo Nordisk as it hits its first discovery milestone for its multi-specific nanobody construct, …

Ablynx has achieved a pre-clinical proof-of-concept with a nanobody construct as part of its immuno-oncology collaboration with Merck – triggering …
Dr Andreas Menrad has joined the Belgium-based firm Ablynx as its new chief scientific officer. Dr Menrad has over 20 …

